Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Theriogenology|December 3, 2014
Wee1B depletion promotes nuclear maturation of canine oocytesYu-Gon Kim, Dong-Hoon Kim, Seok-Hwan Song, et al.Nature Communications|January 29, 2015
Temporal and spatial regulation of translation in the mammalian oocyte via the mTOR-eIF4F pathwayAndrej Susor, Denisa Jansova, Renata Cerna, et al.Oncotarget|January 13, 2016
STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancersJae-Sung Kim, Hyun-Ah Kim, Min-Ki Seong, et al.Frontiers in Oncology|October 29, 2020
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast CancerAh-Young Kim, Yi Na Yoon, Jiyeon Leem, et al.Biochemical Pharmacology|August 17, 2017
Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cellsMyeong-Ok Kim, Min Ho Choe, Yi Na Yoon, et al.Cell Cycle (Georgetown, Tex.)|May 6, 2016
Beclin-1 knockdown shows abscission failure but not autophagy defect during oocyte meiotic maturationSeung Yeop You, Yong Seok Park, Hyuk-Joon Jeon, et al.Sensors (Basel, Switzerland)|October 27, 2019
Erratum: Cuvette-Type LSPR Sensor for Highly Sensitive Detection of Melamine in Infant Formulas. Sensors 2018, 19(18), 3839Seo Yeong Oh, Min Ji Lee, Nam Su Heo, et al.Frontiers in Oncology|April 15, 2022
PCW-1001, a Novel Pyrazole Derivative, Exerts Antitumor and Radio-Sensitizing Activities in Breast CancerMinsung Kang, Navin Pandit, Ah-Young Kim, et al.Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and OocytesMinsung Kang, Chijung Kim, Jiyeon Leem, et al.Gene Expression Patterns : GEP|February 2, 2010
Expression analysis of the Adam21 gene in mouse testisChongil Yi, Jong-Min Woo, Cecil Han, et al.Pageof 8